Evidence map›Paper›PMID 27623466›Full record

ArticleJAMA2016

Five-Year Survival After Endosonography vs Mediastinoscopy for Mediastinal Nodal Staging of Lung Cancer.

Jolanda C Kuijvenhoven, Daniël A Korevaar, Kurt G Tournoy, Thomas L A Malfait, Christophe Dooms, Robert C Rintoul, Jouke T Annema

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in JAMA, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Endosonography With or Without Confirmatory Mediastinoscopy for Resectable Lung Cancer: A Randomized Clinical Trial.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Trial
  3. Trial
  4. Review
  5. Article
  6. Mediastinal Staging in Non-Small-Cell Lung Cancer: Saying Goodbye to Mediastinoscopy.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023
    Review
  7. Article
  8. Mediastinal staging for non-small cell lung cancer.Translational lung cancer research · 2021
    Review
  9. Article
  10. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Jolanda C KuijvenhovenDepartment of Respiratory Medicine, Academic Medical Center, Amsterdam, the Netherlands.
Daniël A KorevaarDepartment of Clinical Epidemiology, Biostatistics, and Bioinformatics, Academic Medical Center, Amsterdam, the Netherlands.
Kurt G TournoyDepartment of Respiratory Medicine, Onze-Lieve-Vrouw Hospital, Aalst, Belgium.
Thomas L A MalfaitDepartment of Respiratory Medicine, University Hospital Ghent, Ghent, Belgium.
Christophe DoomsDepartment of Respiratory Medicine, Leuven University Hospitals, Leuven, Belgium.
Robert C RintoulPapworth Clinical Trials Unit Collaboration, Papworth Hospital, Cambridge, United Kingdom.
Jouke T AnnemaDepartment of Respiratory Medicine, Academic Medical Center, Amsterdam, the Netherlands.

Funding

Department of Health 06/302/216
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

EndosonographyMediastinoscopyCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsLymphatic MetastasisLymph NodesNeoplasm StagingSensitivity and Specificity

Identifiers

PMID27623466

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.